Percutaneous Cryoablation of 40 Solid Renal Tumors with US Guidance and CT Monitoring: Initial Experience

Authors:
  • MFMichael A. Farrell
    Michael A. Farrell
  • MCMatthew R. Callstrom
    Matthew R. Callstrom
  • JCJ. William Charboneau
    J. William Charboneau
  • BLBradley C. Leibovich
    Bradley C. Leibovich
  • DPDavid E. Patterson
    David E. Patterson
  • GCGeorge K. Chow
    George K. Chow
  • MBMichael L. Blute
    Michael L. Blute

Abstract
Purpose: To retrospectively determine the safety and effectiveness of percutaneous cryoablation, monitored with computed tomography (CT), for the treatment of solid renal masses. Materials and Methods: This study was compliant with the Health Insurance Portability and Accountability Act and had institutional review board approval; informed consent was waived. From March 12, 2003, through August 4, 2005, 23 men and 17 women (mean age, 76 years ± 9.7 [standard deviation]; range, 53–92 years), each with a single renal tumor, underwent one percutaneous cryoablation treatment session that combined ultrasonographic (US) guidance and CT monitoring. Technical success was defined as extension of the visible ice ball 5 mm beyond the tumor margin. Local tumor progression was defined as any tumor with intralesional enhancement or a serial increase in tumor size when compared with that on images obtained immediately after ablation. Tumor characteristics, complications, and follow-up were evaluated. Results: The maximu...